Key Documents
Marlene Rabinovitch
- Professor, Pediatrics - Cardiology
- Professor (By courtesy), Developmental Biology
- Member, Bio-X
Contact Information
- Clinical Offices
Pediatric Heart Center 725 Welch Rd MC 5912 Palo Alto, CA 94304-1601 Telephone Work (650) 721-2121 Fax
- Academic Offices
Personal Information Email marlener@stanford.eduAdministrative Contact Administrative Associate Email mfox1@stanford.edu Tel Work 723-8239Not for medical emergencies or patient use
Clinical Focus
- Cardiology (Heart), Pediatric
- Pediatric Cardiology
Administrative Appointments
- Director of Research, Vera Moulton Wall Center for Pulmonary Vascular Disease , (2003– present )
Honors and Awards
- Scientific Accomplishment Award, American Thoracic Society (2008)
- Distinguished Scientist Award, American Heart Association (2006)
- Dickinson Richards Lecture, American Heart Association (2005)
- Basic Research Prize, American Heart Association (2004)
- Leadership Award and Prize, CIHR-Institute of Circulatory & Respiratory Health (2004)
- The Gill Award, University of Kentucky (2003)
- Paul Dudley White Lectureship, American Heart Association (2002)
- Dunlevie Endowed Research Chair, Stanford Univeristy (2002)
- Distinguished Scientist Award, MRC (2000)
- Award of Merit, Heart & Stroke Foundation of Canada (1999)
- Endowed Research Chair, Heart & Stroke Foundation of Ontario (1997)
- Julius Comroe Lectureship, American Physiological Society (1996)
- Research Achievement Award, Canadian Cardiovascular Society (1994)
- Cushing Memorial Award in Pediatrics, McGill University, Montreal, Canada (1971)
Professional Education
- Board Certification: Pediatric Cardiology, American Board of Pediatrics (1979)
- Children's Hospital, Harvard Medical School (1977) MA
- Board Certification: General Pediatrics, American Board of Pediatrics (1976)
- University of Colorado Health Science Center (1973) CO
- University of Colorado Health Science Center (1972) CO
- McGill University (1971) Canada
- B.S., McGill Universtiy Physiology/Psychology (1967)
- M.D., McGill University Medicine (1971)
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Community & International Work
- National Heart, Lung, Blood Institute Advisory Council, NIH, Bethesda, MD More »
- Executive Committee, Pulmonary Vascular Research Institute (PVRI) More »
- Canadian Institutes of Health Research, Circulatory and Respiratory Institute Advisory Board More »
- Burroughs Wellcome Fund, Translational Research Advisory Committee More »
- Pulmonary Hypertension Association, Scientific Advisory Board More »
Web Site Links
Research Interests
Our research focuses on the regulation of genes associated with cardiovascular development and disease. We identified a novel smooth muscle cell elastase that has a pivotal role in the pathobiology of pulmonary hypertension, vein graft atherosclerosis, transplant arteriopathy and rejection, coronary artery disease, restenosis, myocardial ischemia and myocarditis. Inhibition of elastase prevents or reverses the pathology in experimental animals. We are now pursuing fundamental studies which address the transcriptional regulation of elastase by AML1 and how this relates to genetic mechanisms of disease, focusing on polymorphisms in the serotonin transporter, mutations in a bone morphogenetic protein receptor, and overexpression of a calcium binding protein, Mts1. These studies use cultured cells, transgenic mice, gene arrays and gene therapy and are aimed at developing new treatments.
In our studies related to regulation of cell motility, a key feature of vascular pathology, we identified a requisite increase in production of the microtubule-associated protein LC-3, which is highly conserved across species. This protein regulates the efficiency of mRNA translation of genes, including fibronectin and apolipoprotein D. We determined that LC3, through its triple arginine motif, engages an AU rich element in the 3’ untranslated region of fibronectin mRNA, to enhance efficiency of mRNA translation. We are now addressing whether this process is critical to the regulation of a constellation of transcripts necessary for cell motility in development and disease. We are pursuing evidence that LC3 is regulated by nitric oxide, and are currently investigating how this leads to its phosphorylation and binding to mRNA. In addition, we are relating LC-3 to the migration of other cell types, including neural crest cells which regulate cardiac development, as well as neuronal cells, where it is highly expressed in development, and in diseased tissues and cancer cells. We are utilizing transgenic mice, RNAi, and transcriptional profiling by DNA microarray approaches to investigate the impact of LC3-dependent mRNA translation on cell function.
We have also cloned a novel chymase that mediates enhanced experimental hypertension through processing angiotensin II, endothelin 1, and transforming growth factor beta.
Our research program harmonizes with that of Dr. Richard Bland who investigates the regulation, expression and function of genes that coordinate pulmonary alveolar and vascular development, and how they are perturbed by prematurity and mechanical ventilation, leading to chronic lung disease.
Clinical Trials
Publications
- Circ Res. 2009; (7): 639-47, 13 p following 647
- J Cell Biol. 2009; (1): 83-99
- Am J Physiol Lung Cell Mol Physiol. 2009;
- J Clin Invest. 2008; (5): 1846-57
- Development. 2008; (17): 2981-91
- Am J Physiol Lung Cell Mol Physiol. 2009;
- J Cell Biochem. 2009; (2): 433-46
- Cardiol Young. 2009; 13-5
- Eur Respir J. 2009; (2): 318-24
- J Clin Invest. 2008; (7): 2372-9
- J Exp Med. 2008; (2): 361-72
- Dev Dyn. 2008; (1): 187-95
- Circ Res. 2008; (3): 380-8
- Am J Physiol Lung Cell Mol Physiol. 2008; (2): L276-89
- Am J Physiol Lung Cell Mol Physiol. 2008; (1): L3-14
- FASEB J. 2008; (10): 3571-80
- J Appl Physiol. 2007; (4): 1449-51
- Am J Physiol Lung Cell Mol Physiol. 2007; (5): L1099-110
- Annu Rev Pathol. 2007; 369-99
- Am J Respir Crit Care Med. 2007; (8): 805-15
- Am J Physiol Lung Cell Mol Physiol. 2007; (6): L1370-84
- Circulation. 2007; (10): 1275-84
- PLoS Biol. 2005; (5): e156
- Circ Res. 2005; (6): 596-604
- Circ Res. 2005; (3): 227-35
- Pediatr Res. 2005; (5): 976-80
- Circulation. 2005; (3): 423-31
- FASEB J. 2005; (13): 1848-50
- Chest. 2005; (6 Suppl): 642S-646S
- Chest. 2005; (6 Suppl): 577S
- Am J Pathol. 2004; 253-262
- J Am Coll Cardiol. 2004; (12 Suppl S): 13S-24S
- Circulation. 2004; (24): 2947-52
- Circ Res. 2004; (2): 179-86
- Circ Res. 2004; (8): 1001-4
- Am J Pathol. 2004; (1): 253-62
- Am J Physiol Heart Circ Physiol. 2004; (1): H286-92
- Circ Res. 2004; (2): 179-86
- Arterioscler Thromb Vasc Biol. 2003; 2172-2177
- Circulation. 2003; II161-6
- Arterioscler Thromb Vasc Biol. 2003; (12): 2172-7
- Circulation. 2003; (7): 1046-52
- Am J Physiol Heart Circ Physiol. 2003; H286-H292
- Cardiovasc Pathol. 2002 Sep-Oct; (5): 263-71
- Nat Med. 2002; (7): 664-6
- J Clin Invest. 2002; (12): 1561-9
- Am J Obstet Gynecol. 2002; (5): 1085-90
- J Appl Physiol. 2002; (5): 1770-8
- Circulation. 2002; (4): 516-21
- Cardiol Clin. 2002; (3): 441-57, vii
- J Clin Invest. 2001; (6): 703-15
- Circ Res. 2001; (1): 26-32
- Arterioscler Thromb Vasc Biol. 2001; (8): 1269-74
- Clin Chest Med. 2001; (3): 433-49, viii
- J Clin Invest. 2001; (8): 1109-11
- Proc Natl Acad Sci U S A. 2001; (13): 7469-74
- J Thorac Cardiovasc Surg. 2001; (2): 279-89
- J Am Coll Cardiol. 2000; (1): 262-9
- Circ Res. 2000; (4): 261-3
- Circulation. 2000; (19 Suppl 3): III289-95
- Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2000; 63-81
- Circ Res. 2000; (2): 111-3
- Nat Med. 2000; (6): 698-702
- J Clin Invest. 2000; (12): 1687-95
- J Clin Invest. 2000; (1): 21-34
- Am J Respir Cell Mol Biol. 2000; (1): 1-3
- FASEB J. 2000; (5): 805-14
- J Cell Sci. 1999; 435-45
- J Clin Invest. 1999; (8): 1211-9
- Circ Res. 1999; (10): 1223-33
- Infect Immun. 1999; (7): 3199-206
- Am J Physiol. 1999; (1 Pt 1): L5-12
- FASEB J. 1999; (11): 1423-34
- Biol Neonate. 1999; (3): 134-43
- J Heart Lung Transplant. 1999; (11): 1041-53
- Nat Med. 1999; (2): 176-82
- Am J Respir Crit Care Med. 1998; (2): 670-4
- Circ Res. 1998; (3): 252-63
- Circ Res. 1998; (5): 481-9
- Chest. 1998; (3 Suppl): 213S-224S
- Nat Med. 1998; (12): 1383-91
- Pediatr Res. 1998; (6): 865-72
- J Cell Physiol. 1998; (1): 78-89
- J Clin Invest. 1997; (12): 3070-82
- J Cell Biol. 1997; (1): 279-93
- Transplant Proc. 1997; (6): 2585-6
- Cardiovasc Res. 1997; (2): 268-72
- Am J Respir Cell Mol Biol. 1997; (4): 364-5
- Am J Pathol. 1997; (4): 1349-60
- Br J Pharmacol. 1997; (4): 599-608
- Semin Perinatol. 1996; (6): 531-41
- Isr J Med Sci. 1996; (10): 803-8; discussion 809-10
- Circ Res. 1996; (6): 1131-42
- Heart. 1996; (4): 379
- J Cell Physiol. 1996; (3): 495-505
- Braz J Med Biol Res. 1996; (8): 1009-18
- J Clin Invest. 1996; (11): 2452-68
- Exp Cell Res. 1996; (1): 122-31
- Trends Microbiol. 1996; (4): 158-61
- J Heart Lung Transplant. 1995 Nov-Dec; (6 Pt 2): S116-23
- Arterioscler Thromb Vasc Biol. 1995; (12): 2200-6
- Acta Paediatr Jpn. 1995; (6): 657-66
- Am J Respir Crit Care Med. 1995; (4 Pt 1): 1347-52
- Springer Semin Immunopathol. 1995; (4): 443-65
- J Cell Physiol. 1995; (1): 19-29
- J Clin Invest. 1995; (6): 2601-10
- J Pathol. 1995; (2): 175-82
- Br Heart J. 1995; (6): 534-9
- J Am Coll Cardiol. 1995; (1): 110-9
- J Cell Physiol. 1995; (3): 620-33
- J Thorac Cardiovasc Surg. 1995; (5): 1513-9; discussion 1519-20
- Circulation. 1994; (6): 2768-79
- J Cell Physiol. 1994; (1): 121-31
- Am J Pathol. 1994; (1): 202-10
- J Cell Biol. 1994; (2): 563-74
- J Ultrasound Med. 1994; (2): 129-35
- Pediatr Res. 1994; (6): 763-70
- Can J Physiol Pharmacol. 1994; (3): 217-26
- Am J Physiol. 1994; (6 Pt 2): H2303-9
- J Clin Invest. 1994; (3): 1163-71
- Mod Pathol. 1993; (6): 699-706
- Connect Tissue Res. 1993; (3): 213-21
- J Biol Chem. 1993; (2): 1405-13
- Transplant Proc. 1993; (1 Pt 2): 859-60
- Lab Invest. 1993; (3): 321-31
- J Clin Invest. 1993; (3): 1198-205
- Pediatr Res. 1993; (4 Pt 1): 352-8
- Am J Pathol. 1993; (6): 1772-86
- J Am Coll Cardiol. 1993; (3): 873-82
- J Clin Invest. 1993; (4): 1850-8
- Circulation. 1993; (5 Pt 2): II248-56
- Cardiol Clin. 1993; (4): 675-87
- Br Heart J. 1993; (5): 461-8
- Circulation. 1992; (1): 380-1
- Exp Cell Res. 1992; (2): 344-53
- Lab Invest. 1992; (3): 350-9
- Am Rev Respir Dis. 1992; (1): 213-23
- Am Rev Respir Dis. 1992; (4 Pt 1): 793-7
- J Pediatr. 1992; (2 Pt 1): 321-9
- J Thorac Cardiovasc Surg. 1992; (1): 87-97
- Curr Opin Cardiol. 1992; (1): 124-33
- Toxicol Pathol. 1991; (4 Pt 1): 458-69
- Am J Physiol. 1991; (6 Pt 2): H1716-26
- J Clin Invest. 1991; (6): 2083-94
- Exp Parasitol. 1991; (4): 424-32
- Dev Biol. 1991; (2): 235-47
- Lab Invest. 1991; (2): 187-99
- Prostaglandins. 1991; (5): 463-72
- Am J Physiol. 1991; (4 Pt 2): H1255-67
- ASAIO Trans. 1990 Oct-Dec; (4): 811-6
- Circ Res. 1990; (2): 438-56
- Circulation. 1990; (5 Suppl): IV131-8
- J Card Surg. 1990; (4): 336-46
- Can J Cardiol. 1989 Nov-Dec; (8): 382-8
- Cardiol Clin. 1989; (4): 895-914
- Pediatr Res. 1989; (4): 330-5
- Acta Paediatr Jpn. 1989; (6): 631-40
- Cardiol Clin. 1989; (2): 227-38
- Circ Res. 1989; (4): 814-25
- Adv Pediatr. 1989; 91-115
- Mol Biochem Parasitol. 1988; (2-3): 191-201
- Dev Biol. 1988; (1): 250-8
- Am J Physiol. 1988; (6 Pt 2): H1499-508
- Am J Physiol. 1988; (6 Pt 2): H1484-91
- Ann Thorac Surg. 1988; (4): 384-9
- Lab Invest. 1988; (2): 184-95
- Am J Physiol. 1988; (2 Pt 1): C338-43
- Chest. 1988; (3 Suppl): 119S-126S
- Am J Physiol. 1988; (3 Pt 2): H500-8
- Circ Res. 1987; (6): 797-804
- Circulation. 1987; (5): 1043-52
- Circulation. 1987; (3 Pt 2): III61-6
- J Pediatr. 1987; (3): 423-31
- Am Rev Respir Dis. 1987; (3): 777-9
- J Thorac Cardiovasc Surg. 1987; (4): 498-503
- Tissue Cell. 1987; (2): 177-82
- Can Anaesth Soc J. 1986; (5): 606-28
- J Nucl Med. 1986; (12): 1837-41
- Lab Invest. 1986; (6): 632-53
- Pediatr Cardiol. 1986; (3): 147-54
- Med Phys. 1985 Jan-Feb; (1): 93-8
- Pediatr Pharmacol (New York). 1985; (1): 31-48
- Can Anaesth Soc J. 1985; (4): 364-73
- Circulation. 1985; (3): 471-9
- Pediatr Res. 1985; (10): 1059-67
- Pediatr Res. 1985; (7): 731-7
- Circulation. 1984; (4): 655-67
- Am J Cardiol. 1984; (1): 166-71
- Am J Cardiol. 1984; (1): 211-4
- Am Heart J. 1984; (1): 81-5
- Am J Cardiol. 1984; (7): 884-91
- Prog Cardiovasc Dis. 1983 Jul-Aug; (1): 43-74
- Radiology. 1983; (2): 551-2
- Circ Res. 1983; (4): 432-41
- Circulation. 1983; (5): 1139-46
- Arch Intern Med. 1983; (7): 1484-5
- J Thorac Cardiovasc Surg. 1983; (3): 444-6
- J Am Coll Cardiol. 1983; (1): 63-72
- J Appl Physiol. 1983; (4): 1167-72
- Ann Thorac Surg. 1983; (3): 281-8
- J Nucl Med. 1982; (12): 1076-9
- Am J Cardiol. 1982; (2): 356-61
- Am Heart J. 1982; (2): 292-5
- Am J Cardiol. 1982; (1): 106-11
- J Nucl Med. 1982; (9): 795-8
- Am J Cardiol. 1982; (4): 804-13
- Circulation. 1981; (6): 1234-49
- Br Heart J. 1981; (5): 574-7
- J Pediatr. 1981; (6): 962-7
- Am J Physiol. 1981; (1): H62-72
- Cardiovasc Clin. 1981; (2): 149-69
- Am J Cardiol. 1981; (1): 77-84
- Circulation. 1981; (1): 152-64
- Br Heart J. 1981; (2): 198-205
- Hum Pathol. 1980; (5 Suppl): 499-509
- Am J Physiol. 1979; (6): H818-27
- Am J Cardiol. 1979; (5): 962-8
- J Pediatr. 1979; (2): 244-7
- Radiology. 1979; (1): 223-5
- Circulation. 1978; (6): 1107-22
- Pediatr Res. 1977; (10 Pt 2): 1117-21
- Circulation. 1976; (4): 599-603